CURE Pharmaceutical Adds Healthcare Luminary To Advisory Board, Secures $1 Million Investment as a Bridge to Uplisting
21 févr. 2018 06h00 HE
|
CURE Pharmaceutical
OXNARD, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced Gene Salkind, M.D. joined the company’s...
Oak Therapeutics Announces Results of Bioequivalence Study of Company’s Oral Dissolvable Strip for Tuberculosis
03 oct. 2017 09h00 HE
|
CURE Pharmaceutical
OXNARD, Calif., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Oak Therapeutics, a subsidiary of CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company, has completed...
CURE Pharmaceutical Subsidiary, Oak Therapeutics, Completes Critical Milestone in Phase 1 of NIH Grant to Develop Oral Dissolvable Strip for Tuberculosis
22 août 2017 11h19 HE
|
CURE Pharmaceutical
OXNARD, Calif., Aug. 22, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company, today announced that its subsidiary company, Oak...
CURE Pharmaceutical Enters Partnership to Distribute New Erectile Dysfuntion Drug Using Company’s Proprietary CureFilm™ Into Asian Market
10 août 2017 09h00 HE
|
CURE Pharmaceutical
OXNARD, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development...
Leading OTF Manufacturer CURE Pharmaceutical Comments on New Report Showing Exponential Growth in Thin Film Drug Manufacturing Market
07 juin 2017 11h13 HE
|
CURE Pharmaceutical
OXNARD, Calif., June 07, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development...
Elsevier Recognizes Alzheimer's - Brain Awareness Month with New Book, "A Roadmap for Curing Cancer, Alzheimer's, and Cardiovascular Disease"
06 juin 2017 04h00 HE
|
Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - June 06, 2017) - Elsevier, the information analytics company specializing in science and health, today announced A Roadmap for Curing Cancer, Alzheimer's, and...
CURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting Cannabinoids
31 mai 2017 09h00 HE
|
CURE Pharmaceutical
OXNARD, Calif., May 31, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development...
Alzheimer’s Foundation of America’s Statement on the Trump Administration’s Proposed 2018 Budget
23 mai 2017 15h40 HE
|
Alzheimer's Foundation of America
NEW YORK, May 23, 2017 (GLOBE NEWSWIRE) -- Today, the Trump Administration released its proposed federal budget for fiscal year 2018, which makes deep cuts in funding for the National Institutes of...
CURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate Development
09 mai 2017 09h00 HE
|
CURE Pharmaceutical
OXNARD, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching cannabinoid molecules for various...
CureGrail Launches Collaborative, System-Level Platform to Accelerate Drug Development & Cure Discovery
21 févr. 2017 12h46 HE
|
CureGrail
ORLANDO, Fla. , Feb. 21, 2017 (GLOBE NEWSWIRE) -- Following many years of informal collaboration and institutional data collection, a diverse group of clinical researchers, healthcare business...